Literature DB >> 10221363

Suicide in the course of the treatment of depression.

D Healy1, C Langmaak, M Savage.   

Abstract

Five different mechanisms have been proposed whereby antidepressant treatment might lead to suicide: first by simply ameliorating depressions more rapidly; second by an action intrinsic to the specific antidepressant effects; third by toxicity in overdose; fourth by side-effects of specific antidepressants; and finally by virtue of treatment inefficacy. Evidence from randomized control trials (RCT), controlled case studies and epidemiological studies on this question is reviewed and it is concluded that antidepressants can be implicated in some cases of suicide during treatment. Modifications of clinical trial methods and pharmacogenetic studies would yield a richer data set to explore this issue further.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10221363     DOI: 10.1177/026988119901300110

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  11 in total

1.  In the grip of the python: conflicts at the university-industry interface.

Authors:  David Healy
Journal:  Sci Eng Ethics       Date:  2003-01       Impact factor: 3.525

Review 2.  Ethical issues in psychopharmacology.

Authors:  L McHenry
Journal:  J Med Ethics       Date:  2006-07       Impact factor: 2.903

Review 3.  [Antidepressants and suicidality. Risk-benefit analysis].

Authors:  U Hegerl
Journal:  Nervenarzt       Date:  2007-01       Impact factor: 1.214

Review 4.  Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement.

Authors:  Hans-Jürgen Möller; David S Baldwin; Guy Goodwin; Siegfried Kasper; Ahmed Okasha; Dan J Stein; Rajiv Tandon; Marcio Versiani
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-08       Impact factor: 5.270

5.  Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review.

Authors:  David Gunnell; Julia Saperia; Deborah Ashby
Journal:  BMJ       Date:  2005-02-19

Review 6.  Is there evidence for negative effects of antidepressants on suicidality in depressive patients? A systematic review.

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2006-12-01       Impact factor: 5.270

Review 7.  Identification of suicidal ideation and prevention of suicidal behaviour in the elderly.

Authors:  Katalin Szanto; Ariel Gildengers; Benoit H Mulsant; Greg Brown; George S Alexopoulos; Charles F Reynolds
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

Review 8.  Suicidal behaviour in bipolar disorder: risk and prevention.

Authors:  Leonardo Tondo; Göran Isacsson; Ross Baldessarini
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

9.  Fluoxetine increases suicide ideation less than placebo during treatment of adults with minor depressive disorder.

Authors:  Steven J Garlow; Becky Kinkead; Michael E Thase; Lewis L Judd; A John Rush; Kimberly A Yonkers; David J Kupfer; Ellen Frank; Pamela J Schettler; Mark Hyman Rapaport
Journal:  J Psychiatr Res       Date:  2013-06-17       Impact factor: 4.791

10.  Recurrence of suicidal ideation due to treatment with antidepressants in anxiety disorder: a case report.

Authors:  Doron Todder; Bernhard T Baune
Journal:  J Med Case Rep       Date:  2007-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.